11/17/2026

Pharmapack 2027: Sanner presents enhanced moisture management and sustainability services

November 17, 2026 – At Pharmapack Paris on 27-28 January 2027 (booth 4J59), Sanner will present its global capabilities and its service portfolio for pharmaceutical packaging and medical devices. With enhanced moisture management and sustainability services, the company is strengthening its position as a leading global healthcare packaging and medical device CDMO.

The right moisture protection for every application

Effective moisture management involves much more than simply adding a desiccant to a package or a medical device. Drug formulations, diagnostic products, and medical device components are sensitive to environmental conditions. Moisture exposure can compromise chemical stability, affect physical properties, or reduce product shelf life. Building on its long-standing expertise in drop-in and integrated granular desiccants, Sanner has expanded its portfolio to include hydrated, compressed, and molded desiccant solutions, highly customized to individual application requirements, from pharmaceutical primary packaging to drug delivery systems and diagnostic devices.

 

“Our service commitment extends beyond desiccant products to tailored moisture management solutions for pharmaceutical, consumer health, and medical device applications. We combine our established expertise in desiccant selection and dimensioning, humidity assessment, and shelf-life simulation with expanded capabilities in component development, robustness testing, and design for manufacturability. Working closely with our customers, we identify the right moisture management solution, and translate it into a robust, scalable, and manufacturable packaging or device,”
Jean-Edouard Rabier, CBDO at Sanner

Sustainability built into product development

Sanner continues to expand its innovative portfolio of packaging solutions designed with sustainability and product protection in mind. The portfolio includes mono-material packaging designs that facilitate recyclability, the Sanner BioBase® product range with solutions made from bio-based plastics, and the innovative Tethered Cap concept, which keeps the cap securely attached to the tube packaging even after opening.

Building on this experience, Sanner is now embedding its sustainability services across the medical device development process, helping customers consider environmental impact from the earliest design stages. Through lifecycle assessments, device design, supply chain and transport optimizations, as well as end-of-life considerations, Sanner supports customers in identifying opportunities to reduce environmental impact and substantiate improvements with reliable data.

“Medical devices developed today may remain in production for many years. This makes it essential to consider their environmental impact right from the start,” explains Tom Oakley, VP Strategic Partnerships at Sanner. “With our expertise in both pharmaceutical packaging and medical devices, we guide customers in making informed decisions that balance sustainability, product performance, and regulatory requirements.”

Building resilient supply networks in a changing global environment

Operational resilience also depends on reliable supply under changing market conditions. Recent years have demonstrated the vulnerability of internationally interconnected supply chains. Material shortages, logistical disruptions, geopolitical uncertainty, and fluctuating demand can create significant challenges for healthcare manufacturers. Sanner responds to these challenges with global manufacturing capabilities and access to different regional production environments, with market proximity and opportunities for more flexible capacity planning.

 

“A resilient manufacturing network requires consistent quality systems, transparent production planning, reliable supplier management, and the ability to transfer knowledge and processes across locations,” says Stefan Verheyden, CEO of Sanner. “Standardized manufacturing principles and coordinated engineering expertise support consistency while allowing regional operations to respond to local customer and market needs. With development and manufacturing capabilities across Europe, the Americas, and Asia, Sanner is ideally positioned to support customers with an international operational footprint.”

Meet Sanner at Pharmapack 2027

Visitors to Pharmapack in Paris can learn more about Sanner’s expanded services at booth 4J59 from January 27 to 28, 2027.

On January 27, Stefan Verheyden, CEO of Sanner, will chair the keynote panel discussion on “Formulation-Device Integration: Engineering for Commercial Reality” (2:30-3:15 p.m.). In addition, Tom Oakley, VP Strategic Partnerships at Sanner, will take a leading role in the panel on “Age-Inclusive Device Design: Beyond Compliance to Usability” (11:00-11:45 a.m.). Both sessions will take place in the Pharmapack Conference Theater.

About Sanner

Sanner was founded in 1894. Headquartered in Germany with best-in-class manufacturing facilities across Germany, France, Hungary, China, and the U.S., Sanner has successively developed from a global market leader for desiccant closures and effervescent tablet packaging into a sought-after provider of customized solutions in the areas of medical devices and diagnostics, pharmaceuticals, and consumer healthcare. Today, Sanner supplies its products to more than 150 countries globally and has more than 850 employees. In November 2021, GHO Capital, Europe’s leading specialist investor in healthcare, acquired a majority stake in Sanner to partner with the fourth generation of the Sanner family to continue to support the growth of the company with a specific focus on transforming Sanner into a global MedTech CDMO.

Media Contact

Commha Consulting GmbH & Co. KG
Annette Crowther
Tel. +49 6221 18779-27
sanner@commhaconsulting.com

Downloads

Get in touch with our team today